TS
Thomas Smith Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Equillium
EQ
$114M
| $1.91 | $1 |
48%
downside
| Market Perform |
28 Mar ‘25
5 months ago |
|
2
Q32 Bio
QTTB
$20.4M
| $1.67 | $9 |
439%
upside
| Market Perform |
11 Dec ‘24
9 months ago |
|
3
Aclaris Therapeutics
ACRS
$227M
| $2.10 | $7 |
233%
upside
| Outperform |
19 Nov ‘24
9 months ago |
|
|
ALMS
4
Alumis Inc. Common Stock
ALMS
$469M
| $4.51 | $29 |
543%
upside
| Outperform |
23 Jul ‘24
1 year ago |
|
5
Cartesian Therapeutics
RNAC
$277M
| $10.64 | $39 |
267%
upside
| Outperform |
23 Apr ‘24
1 year ago |
|
6
Sagimet Biosciences
SGMT
$231M
| $7.11 | $26 |
266%
upside
| Outperform |
25 Mar ‘24
1 year ago |
|
7
RAPT Therapeutics
RAPT
$214M
| $12.93 | $80 |
519%
upside
| Market Perform |
21 Feb ‘24
1 year ago |
|
|
ABVX
8
Abivax
ABVX
$6.65B
| $88.03 | $20 |
77%
downside
| Outperform |
14 Nov ‘23
1 year ago |
|
9
argenx
ARGX
$45.9B
| $750.78 | $435 |
42%
downside
| Outperform |
3 Mar ‘23
2 years ago |
|
10
Disc Medicine
IRON
$2.11B
| $60.76 | $36 |
41%
downside
| Outperform |
28 Feb ‘23
2 years ago |
|
|
11
Equillium
EQ
$114M
| $1.91 | $7 |
266%
upside
| Outperform |
8 Feb ‘23
2 years ago |
|
|
CNTB
12
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$97.5M
| $1.75 | $7 |
300%
upside
| Outperform |
8 Feb ‘23
2 years ago |
|
13
Immunovant
IMVT
$2.99B
| $17.14 | $21 |
23%
upside
| Outperform |
6 Feb ‘23
2 years ago |
|
14
Viridian Therapeutics
VRDN
$1.53B
| $18.72 | $45 |
140%
upside
| Outperform |
9 Jan ‘23
2 years ago |
|
15
Trevi Therapeutics
TRVI
$854M
| $7.01 | $6 |
14%
downside
| Outperform |
22 Nov ‘22
2 years ago |
|
16
MannKind Corp
MNKD
$1.7B
| $5.54 | $6 |
8%
upside
| Outperform |
9 Nov ‘22
2 years ago |
|
17
Immunic
IMUX
$75.1M
| $0.7610 | $5 |
557%
upside
| Market Perform |
21 Oct ‘22
2 years ago |
|
18
MoonLake Immunotherapeutics
MLTX
$3.77B
| $59.44 | $17 |
71%
downside
| Outperform |
25 Aug ‘22
3 years ago |
|
19
Celldex Therapeutics
CLDX
$1.52B
| $22.87 | $64 |
180%
upside
| Outperform |
9 Aug ‘22
3 years ago |
|
|
PRTC
20
PureTech Health
PRTC
$392M
| $16.23 | $70 |
331%
upside
| Outperform |
9 Aug ‘22
3 years ago |
|
21
89bio
ETNB
$1.32B
| $8.87 | $29 |
227%
upside
| Outperform |
11 Jul ‘22
3 years ago |
|
22
Eledon Pharmaceuticals
ELDN
$162M
| $2.71 | $26 |
859%
upside
| Outperform |
1 Jun ‘22
3 years ago |
|
23
Viking Therapeutics
VKTX
$3.03B
| $26.98 | $12 |
56%
downside
| Outperform |
28 Apr ‘22
3 years ago |
|
|
GNFT
24
Genfit
GNFT
$197M
| $3.94 | $10 |
154%
upside
| Outperform |
11 Apr ‘22
3 years ago |
|
|
25
RAPT Therapeutics
RAPT
$214M
| $12.93 | $392 |
2,932%
upside
| Outperform |
12 Aug ‘21
4 years ago |
|